Optimal duration of anticoagulation after venous thromboembolism

Circulation. 2011 Feb 15;123(6):664-7. doi: 10.1161/CIRCULATIONAHA.110.970822.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Altitude Sickness / complications
  • Anticoagulants / therapeutic use*
  • Cholesterol, HDL / blood
  • Clinical Trials as Topic
  • Enoxaparin / therapeutic use
  • Female
  • Humans
  • Male
  • Neoplasms / complications
  • Popliteal Vein / diagnostic imaging
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / etiology
  • Risk Factors
  • Sex Factors
  • Ultrasonography
  • Venous Thromboembolism / diagnostic imaging
  • Venous Thromboembolism / drug therapy*
  • Venous Thromboembolism / etiology
  • Warfarin / therapeutic use
  • Young Adult

Substances

  • Anticoagulants
  • Cholesterol, HDL
  • Enoxaparin
  • Warfarin